ARWR EPS Estimates
Arrowhead Pharmaceuticals, Inc.
$58.37
+$0.24(+0.41%)
33
Overall
40
Value
18
Tech
42
Quality
Market Cap
$8.25B
Volume
4.16M
52W Range
$34.61 - $95.49
Target Price
$107.23
ARWR EPS estimates: the consensus estimate for Arrowhead Pharmaceuticals, Inc.'s current fiscal year is -$3.62 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ARWR EPS Estimates
- EPS estimate, current quarter
- $-1.59
- EPS estimate, next quarter
- $-1.23
- EPS estimate, current year
- $-3.62
- EPS estimate, next year
- $-4.73
- EPS growth, 3-year
- +81.84%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.01 |
| 2024 | $-5.00 |
| 2023 | $-1.92 |
| 2022 | $-1.67 |
| 2021 | $-1.36 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARWR | $58.37 | +0.4% | 4.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arrowhead Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW